マルヤマ タクマ
Maruyama Takuma
丸山 拓真 所属 医学部 医学科 職種 助教 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | SUMO1 modification of 0N4R-tau is regulated by PIASx, SENP1, SENP2, and TRIM11. |
掲載誌名 | 正式名:Biochemistry and biophysics reports 略 称:Biochem Biophys Rep ISSNコード:24055808/24055808 |
掲載区分 | 国外 |
巻・号・頁 | 39,pp.101800 |
著者・共著者 | Wada Harmony, Maruyama Takuma, Niikura Takako |
担当区分 | 2nd著者 |
発行年月 | 2024/09 |
概要 | Tau is a microtubule-associated protein that contributes to cytoskeletal stabilization. Aggregation of tau proteins is associated with neurodegenerative disorders such as Alzheimer's disease. Several types of posttranslational modifications that alter the physical properties of tau proteins have been identified. SUMOylation is a reversible modification of lysine residues by a small ubiquitin-like modifier (SUMO). In this study, we examined the enzymes that regulate the SUMOylation and deSUMOylation of tau in an alternatively spliced form, 0N4R-tau. Among SUMO E3 ligases, we found protein inhibitor of activated STAT (PIAS)xα and PIASxβ increase the levels of SUMOylated tau. The deSUMOylation enzymes sentrin-specific protease (SENP)1 and SENP2 reduced the levels of SUMO-conjugated tau. SUMO1 modification increased the level of phosphorylated tau, which was suppressed in the presence of SENP1. Furthermore, we examined the effect of tripartite motif (TRIM)11, which was recently identified as an E3 ligase for SUMO2 modification of tau. We found that TRIM11 increased the modification of both 2N4R- and 0N4R-tau by SUMO1, which was attenuated by mutation of the target lysine residue to arginine. These findings suggest that the expression and activity of SUMOylation regulatory proteins modulate the physical properties of tau proteins and may contribute to the onset and/or progression of tau-associated neurodegenerative disorders. |
DOI | 10.1016/j.bbrep.2024.101800 |
PMID | 39286522 |